Anastrozole

阿那曲唑

Report date: 2026/03/17 10:49:39
NME

Base Information

Drug NameAnastrozole
Drug Alias Name阿纳托(司)唑AnastrozolumAnastrozol阿纳托唑Ansastrozole +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsMenstruation DisturbancesHypogonadismObesity +[12
Global Approved IndicationsBreast NeoplasmsNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1995/08/01
Country/TerritoryCanadaUnited StatesPuerto Rico +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active IndicationsBreast NeoplasmsNeoplasms
Inactive IndicationsMenstruation DisturbancesHypogonadismObesity +[10

Other Information

ATC CodeL02BG03